Mystical-type experiences occasioned by ketamine mediate its impact on at-risk drinking: Results from a randomized, controlled trial

Effects of ketamine treatment on cocaine-induced reinstatement and disruption of functional connectivity in unanesthetized rhesus monkeys

(2019) Eric A. Maltbie et al.   PSYCHOPHARMACOLOGY

A Single Ketamine Infusion Combined With Motivational Enhancement Therapy for Alcohol Use Disorder: A Randomized Midazolam-Controlled Pilot Trial

(2019) Elias Dakwar et al.   AMERICAN JOURNAL OF PSYCHIATRY

A sub-set of psychoactive effects may be critical to the behavioral impact of ketamine on cocaine use disorder: Results from a randomized, controlled laboratory study

(2018) E. Dakwar et al.   NEUROPHARMACOLOGY

Ketamine for the treatment of addiction: Evidence and potential mechanisms

(2018) I. Ivan Ezquerra-Romano et al.   NEUROPHARMACOLOGY

Efficacy of Ketamine in the Treatment of Substance Use Disorders: A Systematic Review

(2018) Jennifer L. Jones et al.   Frontiers in Psychiatry

The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future

(2017) Robin L Carhart-Harris et al.   NEUROPSYCHOPHARMACOLOGY

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

(2016) Roland R Griffiths et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Cocaine self-administration disrupted by the N-methyl-D-aspartate receptor antagonist ketamine: a randomized, crossover trial

(2016) E Dakwar et al.   MOLECULAR PSYCHIATRY

NMDAR inhibition-independent antidepressant actions of ketamine metabolites

(2016) Panos Zanos et al.   NATURE

2010 National and State Costs of Excessive Alcohol Consumption

(2015) Jeffrey J. Sacks et al.   AMERICAN JOURNAL OF PREVENTIVE MEDICINE

Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin

(2015) Alexander V. Lebedev et al.   HUMAN BRAIN MAPPING

Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study

(2015) Michael P Bogenschutz et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review

(2015) Nicolas D. Iadarola et al.   Therapeutic Advances in Chronic Disease

Therapeutic infusions of ketamine: Do the psychoactive effects matter?

(2014) E. Dakwar et al.   DRUG AND ALCOHOL DEPENDENCE

Pharmacotherapy for Adults With Alcohol Use Disorders in Outpatient Settings

(2014) Daniel E. Jonas et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders?

(2014) Gerard Sanacora et al.   NEUROPSYCHOPHARMACOLOGY

The Effects of Subanesthetic Ketamine Infusions on Motivation to Quit and Cue-Induced Craving in Cocaine-Dependent Research Volunteers

(2013) Elias Dakwar et al.   BIOLOGICAL PSYCHIATRY

Family history of alcohol dependence and antidepressant response to anN-methyl-D-aspartate antagonist in bipolar depression

(2012) David A Luckenbaugh et al.   BIPOLAR DISORDERS

Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses

(2012) Michael P. Bogenschutz et al.   Drug Testing and Analysis

Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials

(2012) Teri S Krebs et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Ketamine Decreases Resting State Functional Network Connectivity in Healthy Subjects: Implications for Antidepressant Drug Action

(2012) Milan Scheidegger et al.   PLoS One

Comorbidity and risk indicators for alcohol use disorders among persons with anxiety and/or depressive disorders

(2011) Lynn Boschloo et al.   JOURNAL OF AFFECTIVE DISORDERS

Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness

(2011) Katherine A MacLean et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Signaling pathways underlying the rapid antidepressant actions of ketamine

(2011) Ronald S. Duman et al.   NEUROPHARMACOLOGY

Spirituality in Recovery: A Lagged Mediational Analysis of Alcoholics Anonymous’ Principal Theoretical Mechanism of Behavior Change

(2010) John F. Kelly et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists

(2010) N. Li et al.   SCIENCE

Human hallucinogen research: guidelines for safety

(2008) MW Johnson et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later

(2008) RR Griffiths et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors

(2007) Sungho Maeng et al.   BIOLOGICAL PSYCHIATRY